Stathmin

From WikiMD's WELLNESSPEDIA

PDB_1z2b_EBI.jpg

Stathmin is a highly conserved protein that plays a crucial role in the regulation of the microtubule dynamics within the cell. It is also known as oncoprotein 18 (Op18), phosphoprotein p19, 19K, and metablastin. Stathmin is encoded by the STMN1 gene in humans.

Structure[edit]

Stathmin is a small, cytoplasmic phosphoprotein composed of 149 amino acids. It contains several phosphorylation sites that are critical for its function. The protein has a coiled-coil structure that allows it to interact with tubulin and other microtubule-associated proteins.

Function[edit]

Stathmin regulates microtubule dynamics by promoting microtubule depolymerization. It binds to tubulin heterodimers, preventing their polymerization into microtubules. This activity is regulated by phosphorylation; when stathmin is phosphorylated, its ability to bind tubulin is inhibited, allowing microtubule polymerization to proceed.

Role in Cell Cycle[edit]

Stathmin is involved in the regulation of the cell cycle, particularly during mitosis. It ensures proper spindle formation and function, which is essential for accurate chromosome segregation. Dysregulation of stathmin activity can lead to aneuploidy and has been implicated in cancer development.

Clinical Significance[edit]

Overexpression of stathmin has been observed in various types of cancer, including breast cancer, leukemia, and lymphoma. Due to its role in cell division and its overexpression in tumors, stathmin is considered a potential target for cancer therapy. Inhibitors of stathmin function are being explored as therapeutic agents.

Research[edit]

Ongoing research is focused on understanding the precise mechanisms by which stathmin regulates microtubule dynamics and its role in cancer progression. Studies are also investigating the potential of stathmin as a biomarker for cancer diagnosis and prognosis.

See also[edit]

References[edit]


External links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.